MKI67 and breast carcinoma: Gallen consensus recommended the guidelines setby the International Ki67 in Breast Cancer Working Group (IKWG): patients with lowKi67 < 5% are not recommended for adjuvant chemotherapy whilst patients with a highKi67 ≥ 30% are recommended [21].